Report: Biotech revenue, spending on R&D rose in 2011

09/26/2012 | PharmaTimes (U.K.) · Pharmalot.com

Biotech companies, on average, generated $76 million in revenues last year, up 24% compared with 2010, according to a report from consulting firm BDO USA. On average, research and development spending grew to $50 million from about $47 million in 2010. Major biotechs with revenues surpassing $50 million reported a 33% increase in revenue, but smaller biotechs reported a 12% decline.

View Full Article in:

PharmaTimes (U.K.) · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT